Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal

被引:15
|
作者
Meisel, Andreas [1 ]
Baggi, Fulvio [2 ]
Behin, Anthony [3 ]
Evoli, Amelia [4 ,5 ]
Kostera-Pruszczyk, Anna [6 ]
Mantegazza, Renato [2 ]
Morales, Raul Juntas [7 ]
Punga, Anna Rostedt [8 ]
Sacconi, Sabrina [9 ]
Schroeter, Michael [10 ]
Verschuuren, Jan [11 ]
Crathorne, Louise [12 ]
Holmes, Kris [12 ]
Leite, Maria-Isabel [13 ]
机构
[1] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Integrated Myasthenia Gravis Ctr, Dept Neurol, Berlin, Germany
[2] Fdn Carlo Besta Neurol Inst, Neuroimmunol & Neuromuscular Dis Unit, Sci Inst Res & Hlth Care, Milan, Italy
[3] Hop La Pitie Salpetriere, Publ Hosp Network Paris, Inst Myol, Dept Neuromyol, Paris, France
[4] Univ Cattolica Sacro Cuore, Rome, Italy
[5] Agostino Gemelli Univ Polyclin Fdn, Sci Inst Res & Hlth Care, Rome, Italy
[6] Med Univ Warsaw, Dept Neurol, Warsaw, Poland
[7] Vall dHebron Univ Hosp, Neurol Dept, Barcelona, Spain
[8] Uppsala Univ, Dept Med Sci, Clin Neurophysiol, Uppsala, Sweden
[9] Nice Univ Hosp Ctr, Nice, France
[10] Univ Hosp Cologne, Dept Neurol, Cologne, Germany
[11] Leiden Univ, Med Ctr, Neurol, Leiden, Netherlands
[12] Prescript Commun, Letchworth, England
[13] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England
关键词
autoantibodies; biomarkers; myasthenia gravis; ANTIACETYLCHOLINE RECEPTOR ANTIBODY; ACETYLCHOLINE-RECEPTOR; DISEASE SEVERITY; TITIN-ANTIBODIES; PROTEIN; MUSK; ASSOCIATION;
D O I
10.1111/ene.15565
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose Although myasthenia gravis (MG) is recognized as an immunoglobulin G autoantibody-mediated disease, the relationship between autoantibody levels and disease activity in MG is unclear. We sought to evaluate this landscape through systematically assessing the evidence, testing the impact of predefined variables on any relationship, and augmenting with expert opinion. Methods In October 2020, a forum of leading clinicians and researchers in neurology from across Europe (Expert Forum for Rare Autoantibodies in Neurology in Myasthenia Gravis) participated in a series of virtual meetings that took place alongside the conduct of a systematic literature review (SLR). Results Forty-two studies were identified meeting inclusion criteria. Of these, 10 reported some correlation between a patient's autoantibody level and disease severity. Generally, decreased autoantibody levels (acetylcholine receptor, muscle-specific kinase, and titin) were positively and significantly correlated with improvements in disease severity (Quantitative Myasthenia Gravis score, Myasthenia Gravis Composite score, Myasthenia Gravis Activities of Daily Living score, Myasthenia Gravis Foundation of America classification). Given the limited evidence, testing the impact of predefined variables was not feasible. Conclusions This first SLR to assess whether a correlation exists between autoantibody levels and disease activity in patients with MG has indicated a potential positive correlation, which could have clinical implications in guiding treatment decisions. However, in light of the limited and variable evidence, we cannot currently recommend routine clinical use of autoantibody level testing in this context. For now, patient's characteristics, clinical disease course, and laboratory data (e.g., autoantibody status, thymus histology) should inform management, alongside patient-reported outcomes. We highlight the need for future studies to reach more definitive conclusions on this relationship.
引用
收藏
页码:266 / 282
页数:17
相关论文
共 50 条
  • [31] Circulating microRNAs as potential biomarkers in myasthenia gravis patients
    Punga, Anna Rostedt
    Punga, Tanel
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1412 (01) : 33 - 40
  • [32] Thymectomy: its role in the management of myasthenia gravis
    O'Riordan, JI
    Miller, DH
    Mottershead, JP
    Pattison, C
    Hirsch, NP
    Howard, RS
    EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (02) : 203 - 209
  • [33] THYMECTOMY: ITS ROLE IN THE MANAGEMENT OF MYASTHENIA GRAVIS
    Spillane, J.
    Kullmann, D. M.
    Taylor, C.
    Hirsch, N. P.
    Howard, R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (11): : E62 - E63
  • [34] Myasthenia Gravis and Vitamin D Serum Levels: A Systematic Review and Meta-analysis
    Bonaccorso, Giovanni
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (05) : 752 - 760
  • [35] Serum BAFF levels in patients with myasthenia gravis
    Kang, S.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S207 - S208
  • [36] MYASTHENIA-GRAVIS - REVIEW OF DIAGNOSIS AND MANAGEMENT
    PATTEN, BM
    MUSCLE & NERVE, 1978, 1 (03) : 190 - 205
  • [37] Serum irisin levels in patients with myasthenia gravis
    Zhang, Sheng-Nan
    Li, Qi
    Zhang, Qiu-Xia
    Gao, Tian-Xiao
    Chang, Sheng-Hui
    Zhang, Da-Qi
    Zhang, Lin-Jie
    Yang, Li
    NEUROLOGICAL SCIENCES, 2022, 43 (04) : 2785 - 2790
  • [38] Serum irisin levels in patients with myasthenia gravis
    Sheng-Nan Zhang
    Qi Li
    Qiu-Xia Zhang
    Tian-Xiao Gao
    Sheng-Hui Chang
    Da-Qi Zhang
    Lin-Jie Zhang
    Li Yang
    Neurological Sciences, 2022, 43 : 2785 - 2790
  • [39] TUBERCULOSIS INFECTION IN MYASTHENIA GRAVIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Sayed, Ahmed Kamal
    Elmaraezy, Ahmed
    Taha, Elsayed Ali
    Qureshi, Zaheer Ahmad
    Doheim, Mohamed Fahmy
    Dila, Kadek Agus Surya
    Ahmed, Doaa Alaa Ibrahim
    Hirayama, Kenji
    Nguyen Tien Huy
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 176 - 176
  • [40] Thyroid disorders in patients with myasthenia gravis: A systematic review and meta-analysis
    Song, Rong-hua
    Yao, Qiu-ming
    Wang, Bin
    Li, Qian
    Jia, Xi
    Zhang, Jin-an
    AUTOIMMUNITY REVIEWS, 2019, 18 (10)